OBJECTIVES: The Care and Prevention in the United States Demonstration Project aimed to reduce HIV/AIDS-related morbidity and mortality among racial/ethnic minority groups in 8 states. We evaluated Health Models, a pay-for-performance program piloted by the Louisiana Department of Health that used financial incentives to improve rates of engagement in HIV medical care and viral suppression among people with HIV. METHODS: We enrolled 2076 patients of 3 urban HIV specialty clinics in Louisiana in the Health Models pay-for-performance program on a rolling basis from September 2013 through September 2016 and gave patients cash incentives to attend HIV medical appointments, achieve or maintain viral suppression, and link to supportive services. We used laboratory data collected from Louisiana's HIV surveillance database to calculate rates of engagement in care and viral suppression during the first 24 months of enrollment. RESULTS: Of the 2076 patients who enrolled, 1400 (67.4%) were non-Hispanic black, 1480 (71.3%) were male, 1175 (56.6%) were men who have sex with men, and 1371 (66.0%) reported an annual income of <$15 000. At enrollment, 1456 (70.1%) patients were engaged in HIV care, and 1197 (57.7%) patients were virally suppressed. After 12 months of enrollment, 1474 of 1783 (82.7%) patients were virally suppressed. Of enrolled patients with at least 12 or 24 months of follow-up data, 1299 of 1317 (98.6%) patients were engaged in care during their first 12 months of enrollment, and 995 of 1033 (96.3%) patients were engaged in care between 12 and 24 months of enrollment. CONCLUSIONS: During the implementation of Health Models, enrolled patients had increases in rates of viral suppression and achieved rates of engagement in care and viral suppression that were higher than national levels; however, additional supportive services may be needed to further reduce socioeconomic disparities in the rates of viral suppression.
OBJECTIVES: The Care and Prevention in the United States Demonstration Project aimed to reduce HIV/AIDS-related morbidity and mortality among racial/ethnic minority groups in 8 states. We evaluated Health Models, a pay-for-performance program piloted by the Louisiana Department of Health that used financial incentives to improve rates of engagement in HIV medical care and viral suppression among people with HIV. METHODS: We enrolled 2076 patients of 3 urban HIV specialty clinics in Louisiana in the Health Models pay-for-performance program on a rolling basis from September 2013 through September 2016 and gave patients cash incentives to attend HIV medical appointments, achieve or maintain viral suppression, and link to supportive services. We used laboratory data collected from Louisiana's HIV surveillance database to calculate rates of engagement in care and viral suppression during the first 24 months of enrollment. RESULTS: Of the 2076 patients who enrolled, 1400 (67.4%) were non-Hispanic black, 1480 (71.3%) were male, 1175 (56.6%) were men who have sex with men, and 1371 (66.0%) reported an annual income of <$15 000. At enrollment, 1456 (70.1%) patients were engaged in HIV care, and 1197 (57.7%) patients were virally suppressed. After 12 months of enrollment, 1474 of 1783 (82.7%) patients were virally suppressed. Of enrolled patients with at least 12 or 24 months of follow-up data, 1299 of 1317 (98.6%) patients were engaged in care during their first 12 months of enrollment, and 995 of 1033 (96.3%) patients were engaged in care between 12 and 24 months of enrollment. CONCLUSIONS: During the implementation of Health Models, enrolled patients had increases in rates of viral suppression and achieved rates of engagement in care and viral suppression that were higher than national levels; however, additional supportive services may be needed to further reduce socioeconomic disparities in the rates of viral suppression.
Entities:
Keywords:
HIV treatment adherence; incentive; viral suppression
Authors: Lisa R Metsch; Daniel J Feaster; Lauren Gooden; Tim Matheson; Maxine Stitzer; Moupali Das; Mamta K Jain; Allan E Rodriguez; Wendy S Armstrong; Gregory M Lucas; Ank E Nijhawan; Mari-Lynn Drainoni; Patricia Herrera; Pamela Vergara-Rodriguez; Jeffrey M Jacobson; Michael J Mugavero; Meg Sullivan; Eric S Daar; Deborah K McMahon; David C Ferris; Robert Lindblad; Paul VanVeldhuisen; Neal Oden; Pedro C Castellón; Susan Tross; Louise F Haynes; Antoine Douaihy; James L Sorensen; David S Metzger; Raul N Mandler; Grant N Colfax; Carlos del Rio Journal: JAMA Date: 2016-07-12 Impact factor: 56.272
Authors: James L Sorensen; Nancy A Haug; Kevin L Delucchi; Valerie Gruber; Evan Kletter; Steven L Batki; Jacqueline P Tulsky; Paul Barnett; Sharon Hall Journal: Drug Alcohol Depend Date: 2006-10-23 Impact factor: 4.492
Authors: Jens D Lundgren; Abdel G Babiker; Fred Gordin; Sean Emery; Birgit Grund; Shweta Sharma; Anchalee Avihingsanon; David A Cooper; Gerd Fätkenheuer; Josep M Llibre; Jean-Michel Molina; Paula Munderi; Mauro Schechter; Robin Wood; Karin L Klingman; Simon Collins; H Clifford Lane; Andrew N Phillips; James D Neaton Journal: N Engl J Med Date: 2015-07-20 Impact factor: 91.245
Authors: Eleni Mantzari; Florian Vogt; Ian Shemilt; Yinghui Wei; Julian P T Higgins; Theresa M Marteau Journal: Prev Med Date: 2015-04-02 Impact factor: 4.018
Authors: Kim M Williams; Raekiela D Taylor; Thomas Painter; William L Jeffries; Cynthia Prather; Pilgrim Spikes; Mesfin S Mulatu; Kirk Henny; Tamika Hoyte; Stephen A Flores Journal: Public Health Rep Date: 2018 Nov/Dec Impact factor: 2.792
Authors: Mesfin S Mulatu; Tamika Hoyte; Kim M Williams; Raekiela D Taylor; Thomas Painter; Pilgrim Spikes; Cynthia Prather; William L Jeffries; Kirk Henny; Tanjina Shabu Journal: Public Health Rep Date: 2018 Nov/Dec Impact factor: 2.792
Authors: Brandon J Hill; Darnell N Motley; Kris Rosentel; Alicia VandeVusse; Charlie Fuller; Shannon M E Bowers; Meghan Williams; Michele Kipke; Lisa Kuhns; Nicole Pashka; Sari Reisner; Justin B DeMonte; Rachel W Goolsby; Betty M Rupp; Nicole Slye; Lisa C Strader; John A Schneider; Lisa Razzano; Robert Garofalo Journal: J Acquir Immune Defic Syndr Date: 2022-05-12 Impact factor: 3.771
Authors: Alexsandra Andrawis; James Tapa; Ivo Vlaev; Daniel Read; Kelly Ann Schmidtke; Eric P F Chow; David Lee; Christopher K Fairley; Jason J Ong Journal: Curr HIV/AIDS Rep Date: 2022-08-05 Impact factor: 5.495
Authors: Sharleen M Traynor; Lisa R Metsch; Lauren Gooden; Maxine Stitzer; Tim Matheson; Susan Tross; Adam W Carrico; Mamta K Jain; Carlos Del Rio; Daniel J Feaster Journal: Drug Alcohol Depend Date: 2021-02-03 Impact factor: 4.492